NUVISAN GmbH
- Website
- nuvisan.com
- Total Funding
- $25.0M
- Last Round
- $25.0M GrantJun 2026
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
NUVISAN GmbH is a Drug Discovery company. It has raised $25.0M in total across 1 round, most recently a $25.0M Grant round in Jun 2026. Investors include Bill & Melinda Gates Foundation.
Funding History
Jun 2026
Investors
Similar Companies

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nuvisan-gmbh"><img src="https://indexed.vc/api/badge/company/nuvisan-gmbh" alt="NUVISAN GmbH on Indexed.vc" width="260" height="76" /></a>
